These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14264355)

  • 21. Is the addition of choleretic agents in multiple double-pigtail biliary stents effective for difficult common bile duct stones in elderly patients? A prospective, multicenter study.
    Lee TH; Han JH; Kim HJ; Park SM; Park SH; Kim SJ
    Gastrointest Endosc; 2011 Jul; 74(1):96-102. PubMed ID: 21531412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [TREATMENT OF SOME HEPATO-BILIARY DISEASES WITH AN ASSOCIATION OF DRUGS WITH CHOLERETIC, CHOLAGOGUE AND HEPATOPROTECTIVE ACTION].
    ABBONA C; GATTO PL; RAFFETTO A; BEZANTE GC
    Arch Maragliano Patol Clin; 1964 Oct; 20():439-56. PubMed ID: 14235315
    [No Abstract]   [Full Text] [Related]  

  • 23. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
    Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
    Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microlithiasis: an important cause of "idiopathic" acute pancreatitis?
    Venneman NG; van Brummelen SE; van Berge-Henegouwen GP; van Erpecum KJ
    Ann Hepatol; 2003; 2(1):30-5. PubMed ID: 15094703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of ursodeoxycholic acid alone and ursodeoxycholic acid plus low-dose acetylsalicylic acid on radiolucent gallstones.
    Tuncer I; Harman M; Mercan R; Oztürk M; Arslan I; Meral C; Türkdoğan MK
    Turk J Gastroenterol; 2003 Jun; 14(2):91-6. PubMed ID: 14614633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of biliary complications in bariatric surgery.
    Desbeaux A; Hec F; Andrieux S; Fayard A; Bresson R; Pruvot MH; Mulliez E
    J Visc Surg; 2010 Aug; 147(4):e217-20. PubMed ID: 20920904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Part II. The systemic treatment of gallstones.
    Tompkins RK
    Adv Surg; 1976; 10():87-98. PubMed ID: 824939
    [No Abstract]   [Full Text] [Related]  

  • 28. Biliary symptoms, gallbladder motility, and cholecystectomy.
    Colecchia A; Festi D
    Hepatology; 2007 Jan; 45(1):259-60. PubMed ID: 17187423
    [No Abstract]   [Full Text] [Related]  

  • 29. [TREATMENT OF FUNCTIONAL DISORDERS OF THE EXTRAHEPATIC BILIARY SYSTEM WITH AGOFELL].
    HERRWERTH E; BRENNER L
    Munch Med Wochenschr; 1964 Jan; 106():218-20. PubMed ID: 14124235
    [No Abstract]   [Full Text] [Related]  

  • 30. Gallstones: Article was disappointing.
    Bateson MC
    BMJ; 2007 Aug; 335(7616):362. PubMed ID: 17717343
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of ursodeoxycholic acid and endoscopic sphincterotomy in long-term stenting for common bile duct stones.
    Nishizawa T; Suzuki H; Takahashi M; Kaneko H; Suzuki M; Hibi T
    J Gastroenterol Hepatol; 2013 Jan; 28(1):63-7. PubMed ID: 23094786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ursodeoxycholic acid as a supplementary treatment in corrected biliary atresia.
    Smaropoulos EC; Kaselas B
    Eur J Pediatr Surg; 2006 Apr; 16(2):138-9. PubMed ID: 16685625
    [No Abstract]   [Full Text] [Related]  

  • 33. A double-blind comparative trial of dihydroxydibutylether in patients with cholesterol gallstones.
    Sama C; Petronelli A; Malavolti M; Mastroroberto G; Roda E
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):95-7. PubMed ID: 6341262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical data on the use in surgery of a drug with cholepoietic, eukinetic and antispastic action].
    De bernardis F; Novielli P; Depalma V
    Rass Int Clin Ter; 1966 Jun; 46(12):644-9. PubMed ID: 4230132
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of choleretics on biliary excretion of cholesterol and bile acids in the rat].
    Grandgeorge M; Duperray B; Pacheco H
    Therapie; 1973; 28(5):1013-28. PubMed ID: 4794353
    [No Abstract]   [Full Text] [Related]  

  • 36. Proceedings: The effect of florantyrone (Zanchol) on the composition of T-tube bile.
    Kirkpatrick JR; Eastwood MA; Mitchell WD
    Gut; 1974 Oct; 15(10):830. PubMed ID: 4434947
    [No Abstract]   [Full Text] [Related]  

  • 37. [RESEARCH AND CLINICO-STATISTICAL EVALUATIONS IN THE THERAPEUTIC EFFICACY OF A NEW SYNTHETIC CHOLERETIC IN THE POST-CHOLECYSTECTOMY SYNDROME].
    BRUNO G; PRINOTTI C; BALZOLA F
    Minerva Gastroenterol; 1964; 10():187-9. PubMed ID: 14247980
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of diseases of the bile ducts with a new choleretic (cholipin)].
    KLEINSCHMIDT W
    Med Monatsschr; 1961 Jun; 15():390-2. PubMed ID: 13756728
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones.
    Miettinen TE; Tarpila S; Gylling H
    Hepatology; 1997 Mar; 25(3):514-8. PubMed ID: 9049189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Choleretics: their collateral effects on bile production].
    Clin Ter; 1971 Aug; 58(4):551-62. PubMed ID: 5158279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.